Clinical Trial Update: S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating triacetyluridine in combination with fluorouracil and leucovorin for unresectable, locally advanced, or metastatic esophageal or gastri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• Triacetyluridine (Triacetyluridine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED